Site Search

... right patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes – biomarker testing being one of the ways we can achieve these outcomes by allowing doctors to understand and target unique markers in a patient’s cancer cells. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due in part to lack of coverage by private health insurance and Medicaid for needed testing. Senate Bill 2201 aims to enable more ...